About this trial

Evaluation of the Tolerance and Benefits of Mandibular Advanced Device (MAD) for Snoring and Sleep Apnea in Patients with Oropharyngeal Cancer (OPC): Mixed Design Study.

Eligibility criteria

Qualifiers

oropharyngeal cancer diagnosis

18 years of age and over

female or male; ratio of 1/4 toward men

had received RTH in the Department of Radiation Oncology,

Disqualifiers

pregnant or breastfeeding woman;

edentation preventing retention of the oral appliance;

taking opioid or anxiolitic type medications;

history of major depression,

Trial design

Treatments tested in this trial

  • Ronco-Onco and MAD

Treatment groups

35 Participants
are divided into 2 treatment groups

Locations

1
CHUMH3X 3E4, MontrealQuebec, Canada

Sponsors and collaborators

Centre hospitalier de l'Université de Montréal (CHUM)

Lead sponsor